BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference

INDIANAPOLIS, Sept. 7, 2011 /PRNewswire/ — BioStorage Technologies, a global
leader in scientific asset management, biomaterial storage and cold chain
logistics, will host its third in a series of four Global Sample Management
Benchmarking Symposia in conjunction with the 4th annual Biorepositories
Conference on Sept. 19, 2011 in Boston. Featuring presentations from a diverse
panel of multidisciplinary professionals and experts within the biobanking
community, the symposium will examine strategies for outsourced and onsite
management of biospecimen samples.

“Biospecimen samples are critical scientific assets important to supporting
today’s research efforts, as well as validating future findings and advancing
the development of novel therapies,” said Gregory Swanberg, Chief Executive
Officer, BioStorage Technologies. “BioStorage Technologies has been a strong
supporter of the Biorepositories Conference since its inception four years ago,
and holding our Global Sample Management Benchmarking in conjunction with such
an impressive event was a natural fit for us.”

The symposium will provide insight into trends, challenges and regulatory
mandates affecting global biorepository operations, including: the emerging need
for samples in specific disease areas, best practices for managing global
patient consent of sample assets, onsite virtual management of sample
inventories and regulatory concerns for sample management in China.

The robust speaker line up includes:

— Dr. John Bloom, President, Bloom Consulting Services, LLC and Special
Government Employee to the FDA
“Emerging Needs in the use of Biorepositories for Drug Development:
Implications for Targeted Disease Therapies and Sample Asset Management”
— Dr. Karina Bienfait, Clinical Pharmacogenomics Operations Lead in
Clinical Pharmacogenomics and Clinical Specimen Management, Merck &
Company
“Best Practices in the Management of Patient Informed Consent”
— Steve Sweeney, Head of Clinical Technologies, Infinity Pharmaceuticals,
Inc.
“Strategies for Improving the Onsite Management of Scientific Sample
Assets”
— Suzanne M. O’Shea, Legal Counsel, Baker and Daniels LLP and former
Regulatory Counsel to the U.S. Food and Drug Administration
“Understanding How to Navigate the Regulatory Environment When Managing
Samples in China”

BioStorage Technologies is also a platinum sponsor of the Biorepositories
Conference, and will host several workshops at the event. Lori Ball, Chief
Operating Officer, BioStorage Technologies, will co-present a workshop titled,
“Manage your Biorepository to Guarantee Full Life-Cycle Specimen Quality” and
Catherine Michael, Sr. Director, Comprehensive Solutions, BioStorage
Technologies, will give a presentation titled, “Incorporate Quality-Control
Methodologies to Identify, Control, and Eliminate Threats to Specimen Longevity
and Stability.”

For more information on the Global Sample Management Benchmarking Symposium,
visit www.biostorage.com.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive
sample management solutions for the bioscience industry. Offering onsite or
outsourced management of sample assets, BioStorage Technologies manages the
complete life-cycle of samples. With a team of global sample experts,
state-of-the-art temperature-controlled storage facilities, and a real-time,
web-based sample intelligence and tracking system, the company supports
customers in maximizing opportunities, minimizing risk and reducing the cost of
sample management. BioStorage Technologies, Inc. is privately held and
headquartered in Indianapolis with an additional full-service site near
Frankfurt, Germany. For more information, visit www.biostorage.com or call +1
(866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com

SOURCE BioStorage Technologies, Inc.